# A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients

> **NCT01468168** · PHASE2 · COMPLETED · sponsor: **Santen Inc.** · enrollment: 183 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** DE-101 Ophthalmic Suspension
- **DRUG:** DE-101 Ophthalmic Suspension
- **DRUG:** DE-101 Ophthalmic Suspension Vehicle

## Key facts

- **NCT ID:** NCT01468168
- **Lead sponsor:** Santen Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2012-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01468168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01468168, "A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01468168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*